CTD 12.5 Tablet
By CTD
Rx
15 Tablet in a Strip

Composition
Chlorthalidone(12.5mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
March, 2028

liver
CTD 12.5 Tablet needs caution when used by those with liver disease. Patients with liver conditions should be careful, as the dosage of CTD 12.5 Tablet might need to be adjusted. It is crucial to consult your doctor before taking this medication. It is advised not to use CTD 12.5 Tablet in patients with severe liver disease.

kidney
CTD 12.5 Tablet requires caution in severe kidney disease. Dosage adjustment may be necessary. Consult your doctor before use; not recommended for these patients.

alcohol
Caution is advised when using CTD 12.5 Tablet with alcohol as it may result in increased drowsiness.

driving
CTD 12.5 Tablet can reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
CTD 12.5 Tablet may not be safe to use during pregnancy. Limited human studies exist, but animal studies suggest potential harm to the developing baby. Always consult your doctor for a thorough evaluation of the benefits and risks before considering its use in pregnancy.

breastfeeding
During breastfeeding, caution is advised when using CTD 12.5 Tablet. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug has left her system, as its slow clearance may build up in the infant.
| Habit Forming | No |
| Chemical Class | Thiazide (Related heterocyclics) |
| Therapeutic Class | CARDIAC |
| Action Class | Low-ceiling Diuretics (Inhibitors of Na+Cl symport) |
₹145.1
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024












